Print

OXiGENE (OXGN) Reports Second Quarter 2012 Financial Results  
8/9/2012 10:17:55 AM

SOUTH SAN FRANCISCO, Calif., Aug. 8, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the quarter and six months ending June 30, 2012.
//-->